Share Price.com
Market Update Economic Events Directors Deals Commodities Prices News Market Movers

Futura targets patient dosing for erectile dysfunction gel by September

Wednesday, 13th June 2018
Futura Medical said it expected to commence first patient dosing of its topical gel for erectile dysfunction, known as MED2002, by the end of September.

Feedback from potential commercial partners had highlighted a desire from some men for a faster-acting treatment than existing pill options, the company said.

'Completion of a significant out-licensing agreement for MED2002 remains a top priority for the company and, whilst negotiations proceed, we will continue to maintain the momentum in the product's development,' Futura said.

Story provided by StockMarketWire.com

Related Shares: Futura Med.

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News



SharePrice.com will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.